These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34531550)

  • 21. Hopeful vision. Gene therapy restores human sight.
    Jabr F
    Sci Am; 2012 Apr; 306(4):15. PubMed ID: 22486105
    [No Abstract]   [Full Text] [Related]  

  • 22. Subretinal Injection of Voretigene Neparvovec-rzyl in a Patient With RPE65-Associated Leber's Congenital Amaurosis.
    Hussain RM; Tran KD; Maguire AM; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):661-663. PubMed ID: 31671202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Qualitative exploration of the visual function impairments and impacts on vision-dependent activities of daily living in Retinitis Pigmentosa and Leber Congenital Amaurosis: content validation of the ViSIO-PRO and ViSIO-ObsRO measures.
    Kay C; Audo I; Naujoks C; Spera C; Fischer MD; Green J; Durham T; Williamson N; Bradley H; Barclay M; Sims J; Banhazi J; Patalano F
    J Patient Rep Outcomes; 2023 Jul; 7(1):74. PubMed ID: 37466759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of human gene therapy for RPE65-associated Leber's congenital amaurosis on visual function: a systematic review and meta-analysis.
    Wang X; Yu C; Tzekov RT; Zhu Y; Li W
    Orphanet J Rare Dis; 2020 Feb; 15(1):49. PubMed ID: 32059734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials.
    Chiu W; Lin TY; Chang YC; Isahwan-Ahmad Mulyadi Lai H; Lin SC; Ma C; Yarmishyn AA; Lin SC; Chang KJ; Chou YB; Hsu CC; Lin TC; Chen SJ; Chien Y; Yang YP; Hwang DK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preserved outer retina in AIPL1 Leber's congenital amaurosis: implications for gene therapy.
    Aboshiha J; Dubis AM; van der Spuy J; Nishiguchi KM; Cheeseman EW; Ayuso C; Ehrenberg M; Simonelli F; Bainbridge JW; Michaelides M
    Ophthalmology; 2015 Apr; 122(4):862-4. PubMed ID: 25596619
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term preservation of cones and improvement in visual function following gene therapy in a mouse model of leber congenital amaurosis caused by guanylate cyclase-1 deficiency.
    Mihelec M; Pearson RA; Robbie SJ; Buch PK; Azam SA; Bainbridge JW; Smith AJ; Ali RR
    Hum Gene Ther; 2011 Oct; 22(10):1179-90. PubMed ID: 21671801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial.
    Koenekoop RK; Sui R; Sallum J; van den Born LI; Ajlan R; Khan A; den Hollander AI; Cremers FP; Mendola JD; Bittner AK; Dagnelie G; Schuchard RA; Saperstein DA
    Lancet; 2014 Oct; 384(9953):1513-20. PubMed ID: 25030840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse Models as Tools to Identify Genetic Pathways for Retinal Degeneration, as Exemplified by Leber's Congenital Amaurosis.
    Chang B
    Methods Mol Biol; 2016; 1438():417-30. PubMed ID: 27150101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nature of the visual loss in observers with Leber's congenital amaurosis caused by specific mutations in RPE65.
    Ripamonti C; Henning GB; Ali RR; Bainbridge JW; Robbie SJ; Sundaram V; Luong VA; van den Born LI; Casteels I; de Ravel TJ; Moore AT; Stockman A
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6817-28. PubMed ID: 25257057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood-Onset Retinal Dystrophy.
    Weleber RG; Pennesi ME; Wilson DJ; Kaushal S; Erker LR; Jensen L; McBride MT; Flotte TR; Humphries M; Calcedo R; Hauswirth WW; Chulay JD; Stout JT
    Ophthalmology; 2016 Jul; 123(7):1606-20. PubMed ID: 27102010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetics with clinical characteristics of Leber congenital amaurosis in the Han population of western China.
    Zhu L; Ouyang W; Zhang M; Wang H; Li S; Meng X; Yin ZQ
    Ophthalmic Genet; 2021 Aug; 42(4):392-401. PubMed ID: 33970760
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment Potential for Macular Cone Vision in Leber Congenital Amaurosis Due to CEP290 or NPHP5 Mutations: Predictions From Artificial Intelligence.
    Sumaroka A; Garafalo AV; Semenov EP; Sheplock R; Krishnan AK; Roman AJ; Jacobson SG; Cideciyan AV
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2551-2562. PubMed ID: 31212307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis.
    Stein L; Roy K; Lei L; Kaushal S
    Expert Opin Biol Ther; 2011 Mar; 11(3):429-39. PubMed ID: 21299439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.
    Hauswirth WW; Aleman TS; Kaushal S; Cideciyan AV; Schwartz SB; Wang L; Conlon TJ; Boye SL; Flotte TR; Byrne BJ; Jacobson SG
    Hum Gene Ther; 2008 Oct; 19(10):979-90. PubMed ID: 18774912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel nonsense variant (c.1499C>G) in CRB1 caused Leber congenital amaurosis-8 in a Chinese family and a literature review.
    Duan W; Zhou T; Jiang H; Zhang M; Hu M; Zhang L
    BMC Med Genomics; 2022 Sep; 15(1):197. PubMed ID: 36115989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leber's congenital amaurosis: an update.
    Fazzi E; Signorini SG; Scelsa B; Bova SM; Lanzi G
    Eur J Paediatr Neurol; 2003; 7(1):13-22. PubMed ID: 12615170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy for heart failure and cardiomyopathies.
    Argirò A; Ding J; Adler E
    Rev Esp Cardiol (Engl Ed); 2023 Dec; 76(12):1042-1054. PubMed ID: 37506969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel gene variants in Polish patients with Leber congenital amaurosis (LCA).
    Skorczyk-Werner A; Niedziela Z; Stopa M; Krawczyński MR
    Orphanet J Rare Dis; 2020 Dec; 15(1):345. PubMed ID: 33308271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.
    Jacobson SG; Cideciyan AV; Ratnakaram R; Heon E; Schwartz SB; Roman AJ; Peden MC; Aleman TS; Boye SL; Sumaroka A; Conlon TJ; Calcedo R; Pang JJ; Erger KE; Olivares MB; Mullins CL; Swider M; Kaushal S; Feuer WJ; Iannaccone A; Fishman GA; Stone EM; Byrne BJ; Hauswirth WW
    Arch Ophthalmol; 2012 Jan; 130(1):9-24. PubMed ID: 21911650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.